Cargando…
Apatinib inhibits glioma cell malignancy in patient-derived orthotopic xenograft mouse model by targeting thrombospondin 1/myosin heavy chain 9 axis
We determined the antitumor mechanism of apatinib in glioma using a patient-derived orthotopic xenograft (PDOX) glioma mouse model and glioblastoma (GBM) cell lines. The PDOX mouse model was established using tumor tissues from two glioma patients via single-cell injections. Sixteen mice were succes...
Autores principales: | Yao, Hui, Liu, Jiangang, Zhang, Chi, Shao, Yunxiang, Li, Xuetao, Yu, Zhengquan, Huang, Yulun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8505401/ https://www.ncbi.nlm.nih.gov/pubmed/34635636 http://dx.doi.org/10.1038/s41419-021-04225-2 |
Ejemplares similares
-
Eribulin prolongs survival in an orthotopic xenograft mouse model of malignant meningioma
por: Nakano, Tomoyuki, et al.
Publicado: (2021) -
Identification of a new mechanism for targeting myosin II heavy chain phosphorylation by Dictyostelium myosin heavy chain kinase B
por: Underwood, Julie, et al.
Publicado: (2010) -
Protocol for derivation of organoids and patient-derived orthotopic xenografts from glioma patient tumors
por: Oudin, Anaïs, et al.
Publicado: (2021) -
Synthesis of myosin heavy and light chains in muscle cultures
Publicado: (1975) -
Caenorhabditis elegans Unc-45 Is a Component of Muscle Thick Filaments and Colocalizes with Myosin Heavy Chain B, but Not Myosin Heavy Chain a
por: Ao, Wanyuan, et al.
Publicado: (2000)